Investing.com - Kura Oncology Inc (NASDAQ: KURA) reported fourth quarter EPS of $-0.55, in line with the analyst estimate of $-0.55. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.
Kura Oncology Inc's stock price closed at $21.76. It is up 118.47% in the last 3 months and up 82.09% in the last 12 months.
Kura Oncology Inc saw 5 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Kura Oncology Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Kura Oncology Inc's Financial Health score is "good performance".
Check out Kura Oncology Inc's recent earnings performance, and Kura Oncology Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar